ProQR Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PRQR and other ETFs, options, and stocks.

About PRQR

ProQR Therapeutics NV is a clinical stage biopharmaceutical company, which engages in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases with a focus on inherited retinal diseases. The company was founded by Daniel Anton de Boer, Gerard J.

CEO

Daniel Anton de Boer

CEODaniel Anton de Boer

Employees

166

Employees166

Headquarters

Leiden, Zuid-Holland

HeadquartersLeiden, Zuid-Holland

Founded

2012

Founded2012

Employees

166

Employees166

PRQR Key Statistics

Market cap

236.20M

Market cap236.20M

Price-Earnings ratio

-4.93

Price-Earnings ratio-4.93

Dividend yield

—

Dividend yield—

Average volume

362.49K

Average volume362.49K

High today

$2.25

High today$2.25

Low today

$2.13

Low today$2.13

Open price

$2.20

Open price$2.20

Volume

152.45K

Volume152.45K

52 Week high

$4.62

52 Week high$4.62

52 Week low

$1.07

52 Week low$1.07

Analyst ratings

100%

of 9 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own PRQR. This list is generated using Robinhood data, and it’s not a recommendation.

ProQR Therapeutics

Why Robinhood?

ProQR Therapeutics NV is a clinical stage biopharmaceutical company, which engages in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases with a focus on inherited retinal diseases. The company was founded by Daniel Anton de Boer, Gerard J. Show more

PRQR Key Statistics

Analyst ratings

100%

People also own

ProQR Therapeutics NV is a clinical stage biopharmaceutical company, which engages in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases with a focus on inherited retinal diseases. The company was founded by Daniel Anton de Boer, Gerard J.